Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Chemomab Therapeutics Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −2 vs. Q4 2023
- Shares held
- 2.66M
- −152.2K (−5.4%) vs. Q4 2023
- Total value
- $2.07M
- +$638.5K (+44.5%) vs. Q4 2023
- New holders
- 3
- 1 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $615.3K |
| Q1 2026 | 15 | $551.9K |
| Q4 2025 | 14 | $606.1K |
| Q3 2025 | 10 | $1.03M |
| Q2 2025 | 14 | $4.91M |
| Q1 2025 | 17 | $4.07M |
| Q4 2024 | 16 | $7.53M |
| Q3 2024 | 15 | $7.14M |
| Q2 2024 | 15 | $2.44M |
| Q1 2024 | 14 | $2.07M |
| Q4 2023 | 16 | $1.43M |
| Q3 2023 | 11 | $2.26M |
| Q2 2023 | 11 | $3.33M |
| Q1 2023 | 13 | $4.56M |
| Q4 2022 | 14 | $10.6M |
| Q3 2022 | 15 | $8.09M |
| Q2 2022 | 13 | $12.2M |
| Q1 2022 | 15 | $15.9M |
| Q4 2021 | 14 | $22.7M |
| Q3 2021 | 15 | $35.9M |
| Q2 2021 | 12 | $58.7M |
| Q1 2021 | 10 | $82.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Chemomab Therapeutics Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 2,241,274 | $1.75M | 0.03% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 213,392 | $166.2K | 0.05% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 39,994 | $31.2K | 0.00% | −16,311−29.0% | Reduced |
| Two Sigma Advisers, LP | 37,800 | $29.4K | 0.00% | +2,400+6.8% | Added |
| Kestra Private Wealth Services, LLC | 31,241 | $24.3K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 26,529 | $20.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 26,185 | $20.4K | 0.00% | +26,185 | New |
| Rhumbline Advisers | 18,627 | $14.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 11,737 | $9.14K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,477 | $8.94K | 0.00% | +11,477 | New |
| Morgan Stanley | 2,797 | $2.18K | 0.00% | −68,118−96.1% | Reduced |
| Moser Wealth Advisors, LLC | 500 | $390 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 44 | $34 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1 | $1 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −32,677−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,047−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,808−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,701−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −585−100.0% | Sold out |